Prevalence of Diabetes and Hypertension among Chronic Obstructive Pulmonary Diseases Patients at a Tertiary Care Centre

Jump To References Section

Authors

  • Nilesh Pandhari Patil
     Former PG Resident, Department of Respiratory Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003 ,IN
  • Satish Kamthe
     Former PG Resident, Department of Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003 ,IN
  • Gauri Suhas Kulkarni
     Former Professor, Department of Respiratory Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003 ,IN
  • Ramesh M. Sundrani
     Former Professor, Department of Respiratory Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003 ,IN
  • Kamlesh Pandhari Patil
     ,IN
  • Japreet Singh M. Khandpur
     Former PG Resident, Department of Respiratory Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003 ,IN

Keywords:

Association, COPD, DM, HTN, Prevalence

Abstract

Background: Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable and treatable disease that is characterized by persistent respiratory symptoms and airflow limitation that is due to airway and/or alveolar abnormalities usually caused by significant exposure to noxious particles or gases. HT and DM have been recognized to coexist with COPD. Several risk factors have been associated with HT and DM in people with COPD: Smoking, systemic inflammation, obesity and physical inactivity. Objective: To estimate Prevalence of diabetes and hypertension in Chronic Obstructive Pulmonary Diseases amongst study participants. Material and Method: The Cross-sectional study was conducted on 161 diagnosed COPD patients from August 2017 to December 2019 in Department of Respiratory Medicine Medical College and Tertiary Health Care Institute Nashik was included. Written informed consent was taken from all study participants and those who gave consent were enrolled in the present study. Result: Out of 161 COPD patients, prevalence of hypertension was 45.96% while prevalence of DM was 22.36%. The Highest prevalence of DM in Female (33.33%), HTN in Male (48%) and both DM and HTN in Female (8.33%), active smokers were mostly associated with DM and/or HTN. In stage IV (71), DM, HTN and both DM and HTN were recorded in maximum no. of cases, whereas in patients of Stage I - COPD least level were found. Increase association of DM and/or HTN increases with severity of obstruction. Conclusion: Prevalence of HTN was recorded more than DM. DM and HTN were found to be more prevalence in severe and very severe COPD patients. The COPD patients should be screened for DM and HTN at the time of diagnosis to prevent DM and/or HTN related complications in COPD patients.

Downloads

Published

2021-01-01

Issue

Volume 8, Issue 1, January-June 2021

Section

Original Article

 

References

Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (Revised 2017).

Reilly JJ, Silverman EK, Shapiro S.D. Harrison’s principles of internal medicine (16th edi. 2004; 1547–60.

Caballero A, Torres-Duque CA, Jaramillo C. Prevalence of COPD in five Colombian cities situated at low, medium and high altitude. Chest. 2008; 1332:343–9. PMid: 17951621. https://doi.org/10.1378/chest.07-1361

Hurd S. The impact of COPD on lung health worldwide: Epidemiology and incidence. Chest. 2000; 117 2 Suppl:1S4S. PMid: 10673465. https://doi.org/10.1378/ chest.117.2_suppl.1S

Clini E, Crisafulli E, Radaeli A, Malerba M. COPD and the metabolic syndrome: Anintriguing association. Internal and Emergency Medicine. 2013; 8:283–9. PMid: 21964838. https://doi.org/10.1007/s11739-011-0700-x

Nussbaumer-Ochsner Y, Rabe KF. Systemic manifestations of COPD. Chest. 2011; 139:165–73. PMid: 21208876. https://doi.org/10.1378/chest.10-1252

Lam K-B.H, Jordan RE, Jiang CQ, Thomas GN, Miller MR, Zhang WS, Adab P. Airflow obstruction and metabolic syndrome: The Guangzhou Biobank Cohort Study. European Respiratory Journal. 2010; 35:317–23. PMid: 19574332. https://doi.org/10.1183/09031936.00024709

Bolton CE, Evans M, Ionescu AA, Edwards SM, Morris RH, Dunseath G, Shale DJ. Insulin resistance and inflammation: A further systemic complication of COPD. Chronic Obstructive Pulmonary Disease. 2007; 4:121–6. PMid: 17530505. https://doi.org/10.1080/15412550701341053

Arne M, Janson C, Janson S, Boman G, Lindqvist U, Berne C, Emtner M. Physical activity and qualityof life in subjects with chronic disease: Chronic Obstructive Pulmonary Disease compared with rheumatoid arthritis and Diabetes Mellitus. Scandinavian Journal of Primary Health Care. 2009; 27:141–7. PMid: 19306158 PMCid: PMC3413185. https://doi.org/10.1080/02813430902808643

Ford ES, Li C, Zhao G. Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. Journal of Diabetes. 2010; 2:180–93. PMid: 20923483. https://doi.org/10.1111/ j.1753-0407.2010.00078.x

Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. 2005; 112:2735–52. PMid: 16157765. https://doi.org/10.1161/CIRCULATIONAHA.105.169404

Ajit E, Bondade K, Rakesh J, Banur A, Raykar P. Prevalence of type 2 Diabetes Mellitus in Chronic Obstructive Pulmonary Disease and its impact on the severity of Chronic Obstructive Pulmonary Disease among patients attending tertiary care center in central Karnataka, Davangere. Indian J Respir Care. 2019; 8:42–5. https://doi. org/10.4103/ijrc.ijrc_42_18

Mahishale V, Angadi N, Metgudmath V, Eti A, Lolly M, Khan S. Prevalence and impact of diabetes, hypertension and cardiovascular diseases in Chronic Obstructive Pulmonary Diseases: A hospital-based cross-section study. J Transl Intern Med. 2015; 155–60. PMid: 27847906 PMCid: PMC4936452. https://doi.org/10.1515/jtim-2015-0019

Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008; 32:962–9. PMid: 18579551. https://doi.org/10.1183/09031936.00012408

Singh R, Prevalence of hypertension in patients with Chronic Obstructive Pulmonary Disease attending respiratory medicine OPD. International Journal of Medical Science and Clinical Invention. 2017; 4(12):3346–8. https:// doi.org/10.18535/ijmsci/v4i12.02

Antonelli Incalzi R, Fuso L, De Rosa M, Forastiere F, Rapiti E, Nardecchia B, Pistelli R. Co-morbidity contributes to predict mortality of patients with Chronic Obstructive Pulmonary Disease. Eur Respir J. 1997; 10:2794–800. PMid: 9493663. https://doi.org/10.1183/09031936.97.10122794

Breyer K, Spruit A, Hanson K, Franssen M, Vanfleteren E, Groenen T, Bruijnzeel L, Wouters F, Rutten P. Prevalence of metabolic syndrome in COPD patients and its consequences. PLoS One. 2014 Jun 20; 9(6):e9801. PMid: 24950070 PMCid: PMC4064974. https://doi.org/10.1371/ journal.pone.0098013

Park HY, Lim SY, Hwang JH, et al. Lung function, coronary artery calcification and metabolic syndrome in 4905 Koreanmales. Respir Med. 2010; 104:1326–35. PMid: 20335013. https://doi.org/10.1016/j.rmed.2010.02.024

Marquis K, Maltais F, Duguay V, Bezeau AM, RN; LeBlanc P, Jcan Jobin J, Poirier P, et al. The metabolic syndrome in patients with Chronic Obstructive Pulmonary Disease. Journal of Cardiopulmonary Rehabilitation, 2005; 25:226–32. PMid: 16056071. https://doi.org/10.1097/ 00008483-200507000-00010

Ravikiran M, Bhansali A, RaviKumar P, Bhansali S, Dutta P, Thakur JS, Sachdeva N, Bhadada S, Walia R. Prevalence and risk factors of metabolic syndrome among Asian Indians: A community survey. Diabetes Research and Clinical Practice. 2010; 89:181–8. PMid: 20381187. https://doi. org/10.1016/j.diabres.2010.03.010

Ameen NM, et al, Mohamed RSED, Mageed NIAE, Wahab MHAE. The metabolic syndrome in patients with Chronic Obstructive Pulmonary Disease. Egyptian Journal of Chest Diseases and Tuberculosis. 2016; 65:593596. https://doi. org/10.1016/j.ejcdt.2016.03.008

Almagro P, Lopez Garcia F, Cabrera F, Montero L, Morchon D, Díez J, et al. Grupo Epoc De La Sociedad Española De MedicinaInterna. Comorbidity and genderrelated differences in patients hospitalized for COPD. The ECCO study. Respir Med. 2010; 104:253–9. PMid: 19879744. https://doi. org/10.1016/j.rmed.2009.09.019

Cazzola M, Bettoncelli G, Sessa E, et al. Prevalence of comorbidities in patients with COPD. Respiration. 2010; 80:112–9. PMid: 20134148. https://doi.org/10.1159/000281880

Bermudez G, Gabriel Jasul Jr., David-Wang A, Jimeno C, Magallanes J, Macalalad-Josue AA. Association of Metabolic Syndrome with the Severity of Airflow Obstruction in Patients with Chronic Obstructive Pulmonary Disease. JASEAN Fed Endocr Soc. 2018; 33(2):181–7.

Akpinar EE, Akpinar S, Ertek S, Sayin S, Gulhan M. Systemic inflammation and metabolic syndrome in stable COPD patients. Tuberk Toraks. 2012; 60(3):230–7. PMid: 23030748. https://doi.org/10.5578/tt.4018